ent amgen · name Amgen · kind company · hub earnings · sub - · tier T1 · v K · symbol AMGN
qa 14/14 (hub 99.4%): its own settled markets where our count matched the result
next 2027-02-02 k:KXEARNINGSMENTIONAMGN-27FEB02 (15 words)
last text 2026-11-03 earnings_call
url https://parrot.markets/earnings/AMGN · as_of 2026-11-11T21:14:30Z
14 words with settled history; top 10 by n · tn/th: last 8 earnings call transcripts 2025-02-04..2026-11-03 · derived data CC BY 4.0 (credit parrot.markets) · not advice (parrot.markets/disclosure)

| w | key | n | y | rate | l10 | tn | th |
|---|---|---|---|---|---|---|---|
| Dazodalibep | dazodalibep | 1 | 1 | 1 | Y | 8 | 3 |
| Imfinzi / Durvalumab | durvalumab\|imfinzi | 1 | 1 | 1 | Y | 8 | 2 |
| Eosinophilic | eosinophilic | 1 | 1 | 1 | Y | 8 | 6 |
| ESMO | esmo | 1 | 1 | 1 | Y | 8 | 2 |
| GLP-1 / GLP | glp\|glp 1 | 1 | 1 | 1 | Y | 8 | 6 |
| Medicare | medicare | 1 | 1 | 1 | Y | 8 | 2 |
| Acquisition | acquisition | 1 | 0 | 0 | n | 8 | 5 |
| Artificial Intelligence (3+ times) | artificial intelligence#3 | 1 | 0 | 0 | n | 8 | 1 |
| Buyback / Buy Back | buy back\|buyback | 1 | 0 | 0 | n | 8 | 0 |
| Litigation | litigation | 1 | 0 | 0 | n | 8 | 1 |